4.3 Article

Unpacking COVID-19 Systems Biology in Lung and Whole Blood with Transcriptomics and miRNA Regulators

Journal

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
Volume 26, Issue 11, Pages 608-621

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/omi.2022.0104

Keywords

COVID-19; systems biology; systems medicine; biomarkers; miRNAs; drug targets

Funding

  1. project IMPReS - Program Competitiveness, Entrepreneurship and Innovation'' (NSRF) [MIS 5047189]
  2. European Union (European Regional Development Fund)

Ask authors/readers for more resources

COVID-19 is a systemic disease that affects various tissues and organs, including the lungs. This study analyzed transcriptomics data from lung and whole blood samples of patients, and identified differentially expressed genes and miRNAs related to COVID-19. These findings offer new insights into the systems biology of COVID-19.
COVID-19 is a systemic disease affecting tissues and organs, including and beyond the lung. Apart from the current pandemic context, we also have vastly inadequate knowledge of consequences of repeated exposures to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the virus causing COVID-19, in multiple organ systems and the whole organism scales when the disease evolves from a pandemic to an endemic state. This calls for a systems biology and systems medicine approach and unpacking the effects of COVID-19 in lung as well as other tissues. We report here original findings from transcriptomics analyses and differentially expressed genes (DEGs) in lung samples from 60 patients and 27 healthy controls, and in whole blood samples from 255 patients and 103 healthy individuals. A total of 11 datasets with RNA-seq transcriptomic data were obtained from the Gene Expression Omnibus and the European Nucleotide Archive. The identified DEGs were used to construct protein interaction and functional networks and to identify related pathways and miRNAs. We found 35 DEGs common between lung and the whole blood, and importantly, 2 novel genes, namely CYP1B1 and TNFAIP6, which have not been previously implicated with COVID-19. We also identified four novel miRNA potential regulators, hsa-mir-192-5p, hsa-mir-221-3p, hsa-mir-4756-3p, and hsa-mir-10a-5p, implicated in lung or other diseases induced by coronaviruses. In summary, these findings offer new molecular leads and insights to unpack COVID-19 systems biology in a whole organism context and might inform future antiviral drug, diagnostics, and vaccine discovery efforts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available